SCHEMBL30202774

SCHEMBL30202774

O=C1CN(C(=O)Oc2ccccc2)CCN1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.64
▸ GAA P10253 1/20 0.50
▸ FAAH O00519 1/20 0.49
▸ TRPV1 Q8NER1 1/20 0.49
▸ KMT2A Q03164 7/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ MGLL Q99685 1/20 0.48
▸ NPC1 O15118 2/20 0.47
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ LMNA P02545 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ CYP3A4 P08684 3/20 0.46
▸ MAPK1 P28482 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ TP53 P04637 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ CYP2C9 P11712 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2106013 0.82 CYP1A2 (0.53) FAAHTRPV1MGLLCYP1A2
SCHEMBL23925146 0.80 L3MBTL1 (0.49) L3MBTL1GAAKMT2AMEN1RAB9A
SCHEMBL2583030 0.79 GAA (0.61) GAAKMT2AMEN1RAB9AMGLL
SCHEMBL92518 0.78 L3MBTL1 (0.56) L3MBTL1GAAKMT2AMEN1RAB9A
SCHEMBL22635853 0.78 L3MBTL1 (0.47) L3MBTL1GAAKMT2AMEN1SMN1; SMN2
SCHEMBL23925097 0.77 L3MBTL1 (0.46) L3MBTL1GAAKMT2AMEN1RAB9A
SCHEMBL1583701 0.77 L3MBTL1 (0.46) L3MBTL1GAAKMT2AMEN1RAB9A
SCHEMBL22635874 0.77 L3MBTL1 (0.46) L3MBTL1GAAKMT2ARAB9ASMN1; SMN2
SCHEMBL22724801 0.76 TRPV1 (0.59) GAAFAAHTRPV1KMT2AMEN1
SCHEMBL10883109 0.76 SIGMAR1 (0.62) L3MBTL1KMT2AMEN1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023022497-A1 SOS1 INHIBITOR AND USE THEREOF 주식회사 카나프테라퓨틱스 2023-02-23 — — WO disclosed
Send feedback